Form 4: Lemaitre Vascular Director Martha Shadan Reports Acquisition of Dividend Equivalent Rights

Director Martha Shadan of Lemaitre Vascular Inc. reported the acquisition of dividend equivalent rights related to previously granted stock awards.

Summary

• Martha Shadan, a director at Lemaitre Vascular Inc., has reported the acquisition of dividend equivalent rights.
• These rights are associated with restricted stock unit awards granted on December 12, 2022, and December 8, 2023, as well as a Performance Share Unit (PSU) award granted on December 12, 2022.
• The dividend equivalent rights vest proportionately with the underlying stock awards.
• A total of 2.0611 dividend equivalent rights were acquired on December 5, 2024.
• Each dividend equivalent right is equivalent to one share of Lemaitre Vascular's common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine insider transaction, which is neither particularly positive nor negative. It is a standard part of corporate governance and compensation practices.

Positives

• The acquisition of dividend equivalent rights indicates continued alignment of director's interests with shareholders.
• The vesting of these rights is tied to the performance of the underlying stock awards, which can incentivize long-term value creation.

Industry Context

This filing is a routine disclosure of insider transactions, which is common in the public company landscape. It reflects the ongoing compensation practices of Lemaitre Vascular.

Comparison to Industry Standards

• The use of dividend equivalent rights is a common practice among publicly traded companies to ensure that holders of restricted stock units and performance share units receive the same economic benefit as common shareholders.
• Many companies in the medical device sector, such as Medtronic and Boston Scientific, also utilize similar equity-based compensation structures.

Stakeholder Impact

• The acquisition of dividend equivalent rights by a director aligns their interests with those of shareholders.
• This type of transaction is part of the company's overall compensation strategy and is not expected to have a significant impact on other stakeholders.

Key Dates

Keywords

dividend equivalent rights, Lemaitre Vascular, Martha Shadan, stock awards, director, LMAT, SEC Form 4